AAAAAA

   
Results: 1-9 |
Results: 9
ACTIVATION OF SEROTONERGIC NEURONS IN THE RAPHE MAGNUS IS NOT NECESSARY FOR MORPHINE ANALGESIA
Authors: GAO KM CHEN DO GENZEN JR MASON P
Citation: Km. Gao et al., ACTIVATION OF SEROTONERGIC NEURONS IN THE RAPHE MAGNUS IS NOT NECESSARY FOR MORPHINE ANALGESIA, The Journal of neuroscience, 18(5), 1998, pp. 1860-1868
THE INTERNET AND MIGRAINE - HEADACHE RESOURCES FOR PATIENTS AND PHYSICIANS
Authors: GENZEN JR
Citation: Jr. Genzen, THE INTERNET AND MIGRAINE - HEADACHE RESOURCES FOR PATIENTS AND PHYSICIANS, Headache, 38(4), 1998, pp. 312-314
USING PRETREATMENT QUALITY-OF-LIFE PERCEPTIONS TO PREDICT RESPONSE TOSUMATRIPTAN IN MIGRAINEURS
Authors: LITAKER DG SOLOMON GD GENZEN JR
Citation: Dg. Litaker et al., USING PRETREATMENT QUALITY-OF-LIFE PERCEPTIONS TO PREDICT RESPONSE TOSUMATRIPTAN IN MIGRAINEURS, Headache, 37(10), 1997, pp. 630-634
USE OF CLINICAL-FEATURES TO PREDICT RESPONSE TO SUMATRIPTAN IN MIGRAINE
Authors: SOLOMON GD LITAKER DG GENZEN JR
Citation: Gd. Solomon et al., USE OF CLINICAL-FEATURES TO PREDICT RESPONSE TO SUMATRIPTAN IN MIGRAINE, Neurology, 46(2), 1996, pp. 4134-4134
IMPACT OF SUMATRIPTAN ON CLINIC UTILIZATION AND COSTS OF CARE IN MIGRAINEURS
Authors: LITAKER DG SOLOMON GD GENZEN JR
Citation: Dg. Litaker et al., IMPACT OF SUMATRIPTAN ON CLINIC UTILIZATION AND COSTS OF CARE IN MIGRAINEURS, Headache, 36(9), 1996, pp. 538-541
PREDICTING RESPONSE TO SUMATRIPTAN
Authors: SOLOMON GD GENZEN JR LITAKER DG
Citation: Gd. Solomon et al., PREDICTING RESPONSE TO SUMATRIPTAN, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 34-34
QUALITY-OF-LIFE ASSESSMENT AMONG MIGRAINE PATIENTS TREATED WITH SUMATRIPTAN
Authors: SOLOMON GD SKOBIERANDA FG GENZEN JR
Citation: Gd. Solomon et al., QUALITY-OF-LIFE ASSESSMENT AMONG MIGRAINE PATIENTS TREATED WITH SUMATRIPTAN, Headache, 35(8), 1995, pp. 449-454
USE OF THE SF-36 TO MEASURE THE IMPACT OF SUMATRIPTAN ON QUALITY-OF-LIFE IN MIGRAINE PATIENTS
Authors: SOLOMON GD SKOBIERANDA FG GENZEN JR
Citation: Gd. Solomon et al., USE OF THE SF-36 TO MEASURE THE IMPACT OF SUMATRIPTAN ON QUALITY-OF-LIFE IN MIGRAINE PATIENTS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 202-202
USE OF A 9-ITEM PAIN SURVEY TO MEASURE THE IMPACT OF SUMATRIPTAN ON QUALITY-OF-LIFE IN MIGRAINE PATIENTS
Authors: SKOBIERANDA FG SOLOMON GD GENZEN JR
Citation: Fg. Skobieranda et al., USE OF A 9-ITEM PAIN SURVEY TO MEASURE THE IMPACT OF SUMATRIPTAN ON QUALITY-OF-LIFE IN MIGRAINE PATIENTS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 202-202
Risultati: 1-9 |